These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18472906)

  • 1. Effect of acute and chronic oral zinc administration in hyperprolactinemic patients.
    Madureira G; Bloise W; Mendonca BB; Brandão-Neto J
    Met Based Drugs; 1999; 6(3):159-62. PubMed ID: 18472906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of zinc administration on thyrotropin releasing hormone-stimulated prolactinemia in healthy men.
    Castro AV; Mendonça BB; Bloise W; Shuhama T; Brandão-Neto J
    Biometals; 1999 Dec; 12(4):347-52. PubMed ID: 10816735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc does not acutely suppress prolactin in normal or hyperprolactinemic women.
    Koppelman MC; Greenwood V; Sohn J; Deuster P
    J Clin Endocrinol Metab; 1989 Jan; 68(1):215-8. PubMed ID: 2491863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral zinc administration on prolactin and thymulin circulating levels in patients with chronic renal failure.
    Travaglini P; Moriondo P; Togni E; Venegoni P; Bochicchio D; Conti A; Ambroso G; Ponticelli C; Mocchegiani E; Fabris N
    J Clin Endocrinol Metab; 1989 Jan; 68(1):186-90. PubMed ID: 2909550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
    Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
    Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
    J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil acute administration: a new dynamic test in hyperprolactinemic states.
    Barbaro D; Faggionato F; Pallini S; Carnesecchi C; Palla A; Bombara M; Falciani C; La Gioia A; Loni G
    Metabolism; 1999 Nov; 48(11):1351-6. PubMed ID: 10582540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc and bromocriptine long-term administration in patients with prolactinomas: effects on prolactin and thymulin circulating levels.
    Travaglini P; Mocchegiani E; De Min C; Re T; Fabris N; Faglia G
    Int J Neurosci; 1991 Jul; 59(1-3):119-25. PubMed ID: 1774132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
    Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
    Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
    MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
    Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute and chronic administration of TRH on TSH and prolactin secretion in normal and hypothyroid rats.
    D'Angelo SA; Wall NR; Bowers CY; Rosa CG
    Neuroendocrinology; 1975; 18(2):161-75. PubMed ID: 809721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
    Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
    Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
    Scott JS; Lakin CA; Oliver JR
    Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of thyrotropin releasing hormone test in 129 patients with suspected tumoral hyperprolactinemia.
    Smircić-Duvnjak L; Vizner B; Korsić M; Sekso M; Berković M
    Coll Antropol; 2002 Dec; 26(2):635-40. PubMed ID: 12528293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects.
    Sarnacchiaro F; Colao A; Merola B; Di Sarno A; Landi ML; Di Somma C; Ferone D; Tolino A; Lombardi G
    J Endocrinol Invest; 1997 Oct; 20(9):513-8. PubMed ID: 9413804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.
    Celani MF; Giambuzzi G; Simoni M; Montanini V
    J Endocrinol Invest; 1987 Aug; 10(4):421-5. PubMed ID: 3119699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hydergine in hyperprolactinemia.
    Tamura T; Satoh T; Minakami H; Tamada T
    J Clin Endocrinol Metab; 1989 Aug; 69(2):470-4. PubMed ID: 2753986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.